Anthem Biosciences Limited (NSE:ANTHEM)
India · Delayed Price · Currency is INR 869.50
-5.00 (-0.57%)
Aug 21, 2026, 3:29 PM IST
Anthem Biosciences Market Cap
Anthem Biosciences has a market cap or net worth of 490.8 billion as of August 21, 2026. Its market cap has increased by 3.93% in one year.
Market Cap
490.80B
Enterprise Value
481.95B
Revenue
20.07B
Ranking
n/a
PE Ratio
86.22
Stock Price
869.50
ChartMarket Cap Chart
Since July 21, 2025, Anthem Biosciences's market cap has increased from 410.17B to 490.80B, an increase of 19.66%. That is a compound annual growth rate of 17.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 490.80B | 34.14% |
| Dec 31, 2025 | 365.89B | -10.80% |
| Jul 21, 2025 | 410.17B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biocon | 672.99B |
| OneSource Specialty Pharma | 175.98B |
| Concord Biotech | 164.38B |
| Blue Jet Healthcare | 112.84B |
| Supriya Lifescience | 64.82B |
| Zota Health Care | 37.66B |
| Dishman Carbogen Amcis | 27.21B |
| Panacea Biotec | 25.18B |